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Background
Malaria is endemic in countries of sub-Saharan Africa
where there is also a high prevalence of HIV-1 infection,
with pregnant women being the population most at risk
to both infections. Epidemiological data and indirect evi-
dence have established a link between placental malaria
and an increased risk for HIV-1 mother-to-child transmis-
sion (MTCT), by unknown mechanisms.
Material and methods
The placenta-derived choriocarcinoma cell line BeWo and
monocyte-derived macrophages (MDM) were infected
with varying doses of luciferase reporter HIV-1 pseudo-
typed with the vesicular stomatitis virus protein G. A
recombinant DBL3γ domain, derived from a placental
Plasmodium falciparum Erythrocyte Membrane Protein 1
(PfEMP1) adhesin domain (DBL3γ-732), that binds to
chondroitin sulfate A (CSA) and a non-CSA-binding
PfEMP1 adhesin domain, DBL1α-varO domain were used
to stimulate infected cells. In some experiments, DBL3γ-
732 was preincubated with the Fab fragment of a specific
or an irrelevant monoclonal antibodies (mAb) that inhib-
its, or not, binding to CSA. TNF-α was measured in the
culture supernatants and luciferase activity was quantified
at different time points in cell lysates to evaluate viral rep-
lication.
Results
Addition of DBL3γ-732 to BeWo cells, led to a dose-
dependent increase of HIV-1 replication of up to 400
times the control level in the absence of DBL3γ-732. This
enhancement was specific since it was inhibited by Fab
fragment of an anti- DBL3γ-732 monoclonal antibody but
not by the Fab of an irrelevant mAb. In contrast, the addi-
tion of DBL1α-varO domain does not increase viral repli-
cation. In MDM which presents surface CSA, both DBL
domains strongly inhibit viral replication. The effect of
DBL3γ-732 on HIV-1 replication is most likely mediated
by TNF-α as this cytokine is significantly increased by
DBL3γ-732 binding to BeWo cells and MDM.
Conclusions
This study shows, for the first time, a direct link between
a P. falciparum antigen and an increase of HIV-1 replica-
tion in placental cells in vitro. If this is occuring in vivo, the
presence of both infections could lead to a higher risk of
HIV-1 in utero transmission. These data underline the
importance of efficient malaria prophylaxis and antiretro-
viral interventions for pregnant women in areas where
HIV-1 and malaria co-circulate.
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